India · Delayed Price · Currency is INR Dr. Agarwal's Health Care Statistics
Total Valuation
NSE:AGARWALEYE has a market cap or net worth of INR 148.46 billion. The enterprise value is 157.23 billion.
| Market Cap | 148.46B |
| Enterprise Value | 157.23B |
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:AGARWALEYE has 317.03 million shares outstanding. The number of shares has increased by 3.13% in one year.
| Current Share Class | 317.03M |
| Shares Outstanding | 317.03M |
| Shares Change (YoY) | +3.13% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 22.48% |
| Owned by Institutions (%) | 19.59% |
| Float | 121.08M |
Valuation Ratios
The trailing PE ratio is 100.74 and the forward PE ratio is 71.38. NSE:AGARWALEYE's PEG ratio is 1.83.
| PE Ratio | 100.74 |
| Forward PE | 71.38 |
| PS Ratio | 6.73 |
| PB Ratio | 7.00 |
| P/TBV Ratio | 17.01 |
| P/FCF Ratio | 208.99 |
| P/OCF Ratio | 28.61 |
| PEG Ratio | 1.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.14, with an EV/FCF ratio of 221.33.
| EV / Earnings | 105.97 |
| EV / Sales | 7.13 |
| EV / EBITDA | 26.14 |
| EV / EBIT | 49.07 |
| EV / FCF | 221.33 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 1.77 |
| Debt / FCF | 15.01 |
| Interest Coverage | 3.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.56% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:AGARWALEYE has paid 850.80 million in taxes.
| Income Tax | 850.80M |
| Effective Tax Rate | 31.49% |
Stock Price Statistics
The stock price has decreased by -14.24% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -14.24% |
| 50-Day Moving Average | 499.95 |
| 200-Day Moving Average | 470.85 |
| Relative Strength Index (RSI) | 38.40 |
| Average Volume (20 Days) | 264,478 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AGARWALEYE had revenue of INR 22.07 billion and earned 1.48 billion in profits. Earnings per share was 4.65.
| Revenue | 22.07B |
| Gross Profit | 9.62B |
| Operating Income | 3.20B |
| Pretax Income | 2.70B |
| Net Income | 1.48B |
| EBITDA | 5.02B |
| EBIT | 3.20B |
| Earnings Per Share (EPS) | 4.65 |
Balance Sheet
The company has 2.84 billion in cash and 10.66 billion in debt, with a net cash position of -7.82 billion or -24.68 per share.
| Cash & Cash Equivalents | 2.84B |
| Total Debt | 10.66B |
| Net Cash | -7.82B |
| Net Cash Per Share | -24.68 |
| Equity (Book Value) | 21.20B |
| Book Value Per Share | 63.93 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 5.19 billion and capital expenditures -4.48 billion, giving a free cash flow of 710.40 million.
| Operating Cash Flow | 5.19B |
| Capital Expenditures | -4.48B |
| Depreciation & Amortization | 1.82B |
| Net Borrowing | -2.23B |
| Free Cash Flow | 710.40M |
| FCF Per Share | 2.24 |
Margins
Gross margin is 43.61%, with operating and profit margins of 14.52% and 6.72%.
| Gross Margin | 43.61% |
| Operating Margin | 14.52% |
| Pretax Margin | 12.24% |
| Profit Margin | 6.72% |
| EBITDA Margin | 22.76% |
| EBIT Margin | 14.52% |
| FCF Margin | 3.42% |
Dividends & Yields
NSE:AGARWALEYE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.13% |
| Shareholder Yield | -3.13% |
| Earnings Yield | 1.00% |
| FCF Yield | 0.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:AGARWALEYE is 584.60, which is 24.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 584.60 |
| Price Target Difference | 24.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 20.77% |
| EPS Growth Forecast (3Y) | 40.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |